AI-powered digital therapeutics delivering personalized behavioral therapy for substance use, insomnia, and anxiety at a fraction of traditional cost.
People worldwide with a mental health disorder
Americans in therapist shortage areas
Cost reduction vs. traditional DTx
Digital therapeutics proved that apps can deliver real clinical outcomes. Then every company that tried it went bankrupt.
The technology was never the problem. FDA cleared the products. Patients improved. But at $1,195 per prescription, insurers refused to pay. The first generation of digital therapeutics failed on economics, not on science. Trellis rebuilds this from the ground up with AI.
A provider identifies a patient who would benefit from behavioral therapy for substance use, insomnia, or anxiety. They prescribe Trellis.
Trellis delivers evidence-based CBT, DBT, and ACT protocols through an AI agent that personalizes every session based on patient progress, mood, and engagement patterns.
Treatment data flows back to the prescribing clinician. Real clinical outcomes, tracked continuously, not just reported quarterly.
Trellis is building the digital therapeutics company that should have existed from the start. Clinical-grade. AI-powered. Actually affordable.